Publications by authors named "Paolo Tundo"

Claim this Profile
A
Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia.
Massimo Fasano, Michele Milella, Sergio Carbonara, Paolo Tundo, Salvatore Minniti

Front Public Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous monitoring of SARS-CoV-2 and bacterial profiles from the air of hospital environments with COVID-19-affected patients.
Maria Rita Perrone, Salvatore Romano, Giuseppe De Maria, Paolo Tundo, Anna Rita Bruno

Aerobiologia (Bologna)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compositional Data Analysis of 16S rRNA Gene Sequencing Results from Hospital Airborne Microbiome Samples.
Maria Rita Perrone, Salvatore Romano, Giuseppe De Maria, Paolo Tundo, Anna Rita Bruno

Int J Environ Res Public Health· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
Luca Rinaldi, Vincenzo Messina, Vito Di Marco, Vincenzo Iovinella, Ernesto Claar, Paolo Tundo

Am J Gastroenterol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance Associated Mutations in HCV Patients Failing DAA Treatment.
Mariantonietta Di Stefano, Giuseppina Faleo, Ahmed Mohamed Farhan Mohamed, Simona Morella, Serena Rita Bruno, Paolo Tundo

New Microbiol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study.
Marcello Persico, Andrea Aglitti, Michele Milella, Carmine Coppola, Vincenzo Messina, Paolo Tundo

Liver Int· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HepaDisk - A new quality of life questionnaire for HCV patients.
Stefano Fagiuoli, Nicola Caporaso, Filomena Morisco, Fabio Buelli, Giuliana Gualberti, Paolo Tundo

Dig Liver Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.
Filomena Morisco, Rocco Granata, Silvia Camera, Antonio Ippolito, Michele Milella, Paolo Tundo

United European Gastroenterol J· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.
Antonio Massimo Ippolito, Michele Milella, Vincenzo Messina, Fabio Conti, Raffaele Cozzolongo, Paolo Tundo

Dig Liver Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.
Cleo Study Group, Antonio Ascione, Luigi Elio Adinolfi, Pietro Amoroso, Angelo Andriulli, Paolo Tundo

World J Hepatol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy.
Laura Gillini, Rosella Centis, Lia D'Ambrosio, Alberto Fedele, Valerio Aprile, Paolo Tundo

Eur Respir J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance.
Orazio Palmieri, Antonio M Ippolito, Maurizio Margaglione, Maria R Valvano, Domenica Gioffreda, Paolo Tundo

Liver Int· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin.
Teresa Santantonio, Massimo Fasano, Evangelista Sagnelli, Paolo Tundo, Sergio Babudieri

Hepatology· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin.
Angelo Andriulli, Vito Di Marco, Maurizio Margaglione, Antonio Massimo Ippolito, Giovanna Fattovich, Paolo Tundo

J Hepatol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome.
Pierfrancesco Grima, Marcello Guido, Roberto Chiavaroli, Francesca Stano, Paolo Tundo

Scand J Infect Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of nontraumatic focal splenic lesions using contrast-enhanced sonography.
Roberto Chiavaroli, Pierfrancesco Grima, Paolo Tundo

J Clin Ultrasound· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of visceral adiposity with increased intrarenal artery resistive index in HIV-1-infected patients receiving highly active antiretroviral therapy.
Pierfrancesco Grima, Antonella Zizza, Marcello Guido, Paolo Tundo, Roberto Chiavaroli

Indian J Sex Transm Dis AIDS· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hepatitis with autoimmune features following a HHV-6: a case report.
Pierfrancesco Grima, Roberto Chiavaroli, Paola Calabrese, Paolo Tundo, Piero Grima

Cases J· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients.
Antonella d'arminio Monforte, Alessandro Cozzi-Lepri, Andrew Phillips, Andrea De Luca, Rita Murri, Paolo Tundo

J Acquir Immune Defic Syndr· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?
Massimo Puoti, Alessandro Cozzi-Lepri, Fausto Ancarani, Raffaele Bruno, Silvia Ambu, Paolo Tundo

Antivir Ther· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study.
Alessandro Cozzi-Lepri, Andrew N Phillips, Antonella d'Arminio Monforte, Nicolò Piersantelli, Anna Orani, Paolo Tundo

J Infect Dis· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis